(Q36351694)

13 August 2017

1 reference

title

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation (English)

1 reference

chronic renal insufficiency

13 August 2017

0 references

0 references

1 reference

Andress DL

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

69

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

33-43

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000045

13 August 2017

exact match

0 references

cites work

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Association between Chronic Kidney Disease and Coronary Artery Calcification: The Dallas Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Phosphate regulation of vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Bone morphogenetic protein expression in human atherosclerotic lesions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

High-density lipoprotein regulates calcification of vascular cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Oxidative stress modulates osteoblastic differentiation of vascular and bone cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Gla-containing proteins of bone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Expression of mRNAs for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at different stages of osteoblastic differentiation and their regulation by 1,25 dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

The macrophage foam cell as a target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Chronic renal failure is a state of cellular calcium toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effect of parathyroidectomy on left-ventricular function in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Survival following parathyroidectomy among United States dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Aortic calcification and the risk of osteoporosis and fractures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Total hip bone mass predicts survival in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1alpha-hydroxylase in the rat kidney. Distinct site and mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Regulation of gp330/megalin expression by vitamins A and D

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Parathyroid hormone decreases renal vitamin D receptor expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Altered gene expression profile in the kidney of vitamin D receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Nongenomic action of 1 alpha,25(OH)(2)-vitamin D3. Activation of muscle cell PLC gamma through the tyrosine kinase c-Src and PtdIns 3-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Antirachitic Activity of 1α-Hydroxyergocalciferol and 1α-Hydroxycholecalciferol in Rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

On the evolving nature of understanding dialysis-related disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Effects of long-term therapy with calcitriol in patients with moderate renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

The role of vitamin D in vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Determinants of progressive vascular calcification in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000045

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000045

1 reference

13 August 2017

1 reference